[Federal Register Volume 79, Number 159 (Monday, August 18, 2014)]
[Notices]
[Pages 48726-48727]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-19542]


-----------------------------------------------------------------------

 DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-58-2014]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; Neolpharma, Inc. (Pharmaceutical 
Products); Caguas, Puerto Rico

    The Puerto Rico Industrial Development Company, grantee of FTZ 7, 
submitted a notification of proposed production activity to the FTZ 
Board on behalf of Neolpharma, Inc. (Neolpharma), located in Caguas, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on August 12, 
2014.
    A separate application for subzone designation at the Neolpharma 
facility was submitted and is being processed under Section 400.31 of 
the FTZ Board's regulations. The facility is used for the production of 
pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity 
would be limited to the specific foreign-status materials and 
components and specific finished products described in the submitted 
notification (as described below) and subsequently authorized by the 
FTZ Board.
    Production under FTZ procedures could exempt Neolpharma from 
customs duty payments on the foreign status components used in export 
production. On its domestic sales, Neolpharma would be able to choose 
the duty rates during customs entry procedures that apply to the 
finished products: Clarithromycin, azithromycin, levothyroxine, 
hydroxyzine pamoate and, hydroxyzine hydrochloride (duty free) for the 
foreign-status inputs noted

[[Page 48727]]

below. Customs duties also could possibly be deferred or reduced on 
foreign status production equipment.
    The components and materials sourced from abroad include sodium 
alginate and the following active pharmaceutical ingredients: 
Clarithromycin, azithromycin monohydrate, levothyroxine sodium, and 
hydroxyzine pamoate (duty rate ranges from free to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is September 29, 
2014.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
[email protected] or (202) 482-1367.

    Dated: August 12, 2014.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2014-19542 Filed 8-15-14; 8:45 am]
BILLING CODE 3510-DS-P